Patent-Pending Brewing Technology
Tailored. Enhanced. Any time of day.
A breakthrough dual-hopper brewing platform built for the world's leading appliance manufacturers — enabling precise caffeine customization without compromising flavor.
The Opportunity
Millions of coffee drinkers love the ritual and flavor of coffee — but stop drinking it after noon. The reason isn't the taste. It's the caffeine. Sleep anxiety, sensitivity, and evening routines force consumers to choose between the coffee they love and the sleep they need.
No existing home brewing system gives consumers precise, real-time control over caffeine content while preserving the full-spectrum flavor they expect from premium coffee. Until now.
Core Innovation
Caffevolve's patent-pending system uses two independent bean hoppers — one caffeinated, one decaffeinated — to blend beans in precise proportions before grinding. The result: consistent flavor at any caffeine level from 0% to 100%, combined with an integrated additive dispensing system for wellness supplements.
Caffevolve™ System Architecture
DRAG THE SLIDER TO ADJUST CAFFEINE LEVEL · EXPERIENCE PRECISION IN REAL TIME
Live Interactive Demonstrations
Four fully interactive models demonstrating the core Caffevolve™ technology — how it works mechanically, and the science behind why it matters.
The Advancara touchscreen UI demonstrates the full consumer experience — from brew customization to additive selection, saved user profiles, and cartridge management.
This mockup is built to spec and reflects the actual user flow patent documentation, serving as a concrete visual for licensing discussions with appliance manufacturers.
Product Portfolio
Business Model
Patent-pending blend-then-grind technology, system architecture, and additive platform. Provisional patent filed February 4, 2026.
Partners like Breville, Fellow, and Ninja manufacture and distribute under their brand, incorporating Caffevolve's technology under license.
Per-unit royalty on every product sold. No manufacturing overhead, no supply chain risk, no distribution complexity.
Why This Model Works
Caffevolve carries no inventory, no production liability, and no capital equipment costs. Partners manufacture at their existing scale and capability.
A single technology platform can be licensed simultaneously to multiple manufacturers across global markets, multiplying revenue without multiplying costs.
Patent-pending status creates a defensible moat. Partners gain exclusivity windows; Caffevolve retains ownership of the underlying technology.
The premium coffee equipment market rewards innovation. Partners are actively seeking differentiation to justify premium price points and drive new consumer adoption.
Partner Value Proposition
The blend-then-grind system has been engineered, prototyped, and technically validated across all three product tiers with documented performance specifications.
Provisional patent filed February 2026 establishes priority. Partners acquire a protected technology advantage, not a commodity feature.
Three distinct product tiers — Originara, Advancara, and Culminara — allow partners to deploy across entry, premium, and commercial segments simultaneously.
No competitor offers precision blend-then-grind caffeine control. Founding license partners gain exclusivity windows before the patent opens to the broader market.
About Caffevolve™
Caffevolve™ Corporation is a coffee brewing technology startup headquartered in Kenosha, Wisconsin, operating on an asset-light IP licensing model. The company was founded on a simple but powerful insight: the coffee market had solved for taste, but never for control.
Our mission is to enable the world's leading appliance manufacturers to offer consumers something genuinely new — complete command over their caffeine intake without any compromise to the coffee experience they love.
We're not building coffee makers. We're building the platform that makes the next generation of coffee makers possible.
Brent conceived the Caffevolve™ platform after recognizing a persistent gap in the premium coffee equipment market — one that no manufacturer had addressed with engineering precision. He leads all technology development, patent strategy, and licensing initiatives for the company from Kenosha, Wisconsin.
Get In Touch
Whether you're a manufacturer exploring a licensing partnership, an investor interested in the opportunity, a specialty roaster interested in the TwinOrigin program, or simply want to learn more — we'd welcome the conversation.
Where We've Been & Where We're Going
Resources
Select the documents most relevant to your interest. All materials are confidential and intended for serious prospective partners and investors only.
Common Questions
No. Caffevolve™ operates a purely asset-light IP licensing model. We design, patent, and support the technology — our licensing partners handle all manufacturing, marketing, and distribution under their own established brand. You bring the production capability; we bring the patented innovation.
The Caffevolve™ license covers the complete Blend-Then-Grind™ technology platform: the dual-hopper proportional bean dispensing method, the dual-auger mechanism, the post-brew Flavor & Wellness additive dispensing system, and the software-driven caffeine scheduling architecture. You receive full engineering specifications, USPTO-compliant technical drawings, and ongoing IP portfolio support.
Caffevolve™ targets a 5–8% royalty rate on the wholesale price of each unit sold. Exact rates, exclusivity terms, territory rights, and minimum annual unit commitments are negotiable and will be formalized in a definitive licensing agreement. We are open to tiered structures that align with volume commitments.
The technology is fully specified and patent-pending with a positive search opinion received in February 2026. Complete engineering documentation and USPTO-compliant technical drawings are ready for review under NDA. Functional prototype development is a planned next step, funded through current investment activity.
Yes. Upon execution of a mutual NDA, Caffevolve™ provides a complete technical review package including all engineering specifications, system architecture documentation, USPTO-compliant drawings, and the full patent claim strategy. Contact Brent Langevin directly to initiate the NDA process.
Territory or category exclusivity is negotiable for founding licensing partners who move early. Caffevolve™ intends to pursue multiple non-exclusive licensees in parallel, so early partners who commit to minimum volume terms may have the opportunity to negotiate exclusivity protections. This is best discussed directly.
Caffevolve™ is a pre-revenue, pre-prototype seed-stage company with a fully developed patent-pending technology platform. In February 2026, we received a positive patentability opinion from Kaufold & Dix Patent Law confirming the novelty of all core innovations. Current investment funds the utility patent filing and initial prototype development.
The current pre-patent valuation is $2.5M, reflecting the provisional patent filing, comprehensive IP documentation, positive search opinion, and fully developed go-to-market strategy. Upon grant of the utility patent, independent research (PitchBook, Greenberg 2013, Farre-Mensa 2017) supports a projected post-patent valuation range of $8M–$12M. Full methodology is detailed in our Post-Patent Valuation Analysis.
Three structures are available at $25K, $50K, and $75K investment levels: a Convertible Note (6% interest, 24-month maturity, $2.5M cap, 20% discount — our recommendation), a SAFE Note (no interest, no maturity, same cap and discount), and Direct Equity (immediate 2.91% ownership at $75K). Full plain-language explanations of each are in the Investment Options Guide.
Investment funds four key activities: filing the full non-provisional utility patent through top-tier IP counsel ($20–$25K), building a functional prototype ($15–$20K), licensing outreach and business development including materials and trade show presence ($10–$15K), and trademark filings plus a 6–12 month operating reserve ($12–$18K).
The primary risks are: patent scope (the USPTO may grant narrower claims than filed), licensing execution (manufacturers may decline to license), market adoption (consumer demand may be lower than projected), and timing (patent prosecution typically takes 2–3 years). A full, unvarnished risk analysis including worst-case scenarios is included in the Investment Options Guide. We strongly recommend consulting your own legal and financial advisors before investing.
Conservative five-year projections assume 1.875M units through 2–6 manufacturing partners, generating $892M in partner revenue and $67.4M in Caffevolve™ royalties. At a $75K convertible note investment converting at the $2.5M cap in a scenario where the company reaches an $8M valuation, your ~$81,750 (with interest) could convert into approximately 3.2% ownership. All projections are forward-looking estimates and not guaranteed.